Temedica and Roche Extend Partnership, Achieving Milestones in Digital Patient Care

Temedica and Roche have expanded their long-standing collaboration, focusing on digital health for improved patient care. The partnership, which has successfully launched apps like Retinora and Brisa, benefits a significant number of patients with specific conditions such as macular degeneration and multiple sclerosis.

The ongoing success of the Brisa app, particularly through its OcreKompass project, marks its fifth anniversary with an extension. These digital companions, grounded in Temedica's advanced app platform, have shown value in scientific studies by enhancing patients' lives and medical care.

Integrated with Temedica’s Real-World Evidence platform Permea, the apps provide insights from research and data analysis, supporting users in managing their conditions and contributing to scientific advancement, while ensuring data protection compliance.